TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group

Charlotte Levin Tykjær  Jørgensen; Christina Annette Bjerre; Bent Laursen Ejlertsen; Karsten D. Bjerre; Eva Balslev; Annette Bartels; Nils Brünner; Dorte L. Nielsen

doi:10.1186/1471-2407-14-360

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group

Charlotte Levin Tykjær Jørgensen, Christina Annette Bjerre, Bent Laursen Ejlertsen, Karsten D. Bjerre, Eva Balslev, Annette Bartels, Nils Brünner, Dorte L. Nielsen

6 Citations (Scopus)

784 Downloads (Pure)

Original language	English
Article number	360
Journal	B M C Cancer
Volume	14
Number of pages	14
ISSN	1471-2407
DOIs	https://doi.org/10.1186/1471-2407-14-360
Publication status	Published - 22 May 2014

Keywords

TIMP-1
Gemcitabine
Docetaxel
Breast cancer
Prediction
Prognosis

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/1471-2407-14-360

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer; results from a randomized phase III trial from the Danish breast cancer cooperative groupFinal published version, 618 KB

Cite this

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group. / Jørgensen, Charlotte Levin Tykjær; Bjerre, Christina Annette; Ejlertsen, Bent Laursen et al.
In: B M C Cancer, Vol. 14, 360, 22.05.2014.

Research output: Contribution to journal › Journal article › Research › peer-review

@article{07ba8e8fd6e74bc69030267929e2173d,

title = "TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group",

keywords = "TIMP-1, Gemcitabine, Docetaxel, Breast cancer, Prediction, Prognosis",

author = "J{\o}rgensen, {Charlotte Levin Tykj{\ae}r} and Bjerre, {Christina Annette} and Ejlertsen, {Bent Laursen} and Bjerre, {Karsten D.} and Eva Balslev and Annette Bartels and Nils Br{\"u}nner and Nielsen, {Dorte L.}",

year = "2014",

month = may,

day = "22",

doi = "10.1186/1471-2407-14-360",

language = "English",

volume = "14",

journal = "B M C Cancer",

issn = "1471-2407",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - TIMP-1 and responsiveness to gemcitabine in advanced breast cancer

T2 - results from a randomized phase III trial from the Danish breast cancer cooperative group

AU - Jørgensen, Charlotte Levin Tykjær

AU - Bjerre, Christina Annette

AU - Ejlertsen, Bent Laursen

AU - Bjerre, Karsten D.

AU - Balslev, Eva

AU - Bartels, Annette

AU - Brünner, Nils

AU - Nielsen, Dorte L.

PY - 2014/5/22

Y1 - 2014/5/22

KW - TIMP-1

KW - Gemcitabine

KW - Docetaxel

KW - Breast cancer

KW - Prediction

KW - Prognosis

U2 - 10.1186/1471-2407-14-360

DO - 10.1186/1471-2407-14-360

M3 - Journal article

C2 - 24884504

SN - 1471-2407

VL - 14

JO - B M C Cancer

JF - B M C Cancer

M1 - 360

ER -

TIMP-1 and responsiveness to gemcitabine in advanced breast cancer: results from a randomized phase III trial from the Danish breast cancer cooperative group

Keywords

UN SDGs

Access to Document

Fingerprint

Cite this